ROME, June 27, 2025 /PRNewswire/ — The Alfredo alla Scrofa restaurant celebrates 111 years of history, confirming its position as a historic establishment in the capital. Founded on December 1, 1914, this iconic Roman restaurant is world-renowned for its famous Fettuccine all’Alfredo, a dish that has captured palates and hearts far beyond Italian borders. Continue… Continue reading Alfredo alla Scrofa: 111 Years of History for a Roman Culinary Institution
Category: News Type
MOEA Technology R&D Pavilion Unveils Smart Cycling Innovation at EUROBIKE 2025!
FRANKFURT, Germany, June 27, 2025 /PRNewswire/ — Numerous exhibitors will present their latest products and innovations at EUROBIKE 2025, highlighting the new advancements in the cycling industry. The Cycling and Health Tech Industry R&D Center (CHC) is showcasing its smart mobility with its latest research and development capability, with support from the Department of Industrial Technology,… Continue reading MOEA Technology R&D Pavilion Unveils Smart Cycling Innovation at EUROBIKE 2025!
Keio Plaza Hotel Tokyo to Regularly Hold Hands-on Workshops of Dyeing, Traditional Craft Rooted in Shinjuku, in July Together with Shinjuku Textile Dyers Association
-Creating Value of Hotel Stay through Experience of Japanese Culture- TOKYO, June 27, 2025 /PRNewswire/ — Keio Plaza Hotel Co., Ltd. will regularly hold workshops to experience dyeing to enjoy the tradition of Shinjuku, starting July 9 (Wednesday), 2025, so that participants can learn and experience the charm of the local dyeing industry in a… Continue reading Keio Plaza Hotel Tokyo to Regularly Hold Hands-on Workshops of Dyeing, Traditional Craft Rooted in Shinjuku, in July Together with Shinjuku Textile Dyers Association
Three Industry Leaders in Rare Earth Magnets Join Forces Under New Name – Permag
ELK GROVE VILLAGE, Ill., June 27, 2025 /PRNewswire/ — The parent company of Dexter Magnetic Technologies (DMT), Magnetic Component Engineering (MCE), and Electron Energy Corporation (EEC)—Magnetic Holdings, LLC—has been rebranded as Permag. The new name marks the next step in the company’s evolution as the industry leader in high-performance magnetic solutions, leveraging the unique strengths… Continue reading Three Industry Leaders in Rare Earth Magnets Join Forces Under New Name – Permag
DXC Opens Farnborough Office, Launches Aerospace and Defense Hub in the UK
ASHBURN, Va., June 26, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the official opening of its office in Farnborough, a state-of-the-art location that is home to DXC’s dedicated Aerospace and Defense Hub. This milestone follows the recent opening of DXC’s first office in Toronto and… Continue reading DXC Opens Farnborough Office, Launches Aerospace and Defense Hub in the UK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders
NEW YORK, June 27, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: SigmaTron International, Inc. (NASDAQ: SGMA)’s sale to Transom Capital Group, LLC for $3.02 per share in cash. If you are… Continue reading SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders
NEW YORK, June 27, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Carisma Therapeutics Inc. (NASDAQ: CARM)’s merger with OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are… Continue reading SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease
Approval based on the pooled analysis of our pivotal EMERALD and NI-0501-06 studies, showing 54% of patients treated with Gamifant achieved complete response at week 8. STOCKHOLM, June 28, 2025 /PRNewswire/ — Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® (emapalumab-lzsg) for the treatment of adult and pediatric (newborn… Continue reading FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease
Approval based on the pooled analysis of our pivotal EMERALD and NI-0501-06 studies, showing 54% of patients treated with Gamifant achieved complete response at week 8. STOCKHOLM, June 28, 2025 /PRNewswire/ — Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® (emapalumab-lzsg) for the treatment of adult and pediatric (newborn… Continue reading FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still’s disease
HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER “HBNB”
Celebrated Public Listing by Ringing the Opening Bell Today at the Nasdaq Stock Exchange SINGAPORE, June 27, 2025 /PRNewswire/ — Hotel101 Global Holdings Corp. (“Hotel101” or “HBNB”), an asset-light, prop-tech hospitality platform business designed for rapid global growth, announced that it has received approval to list on the Nasdaq Stock Exchange, and its shares are set to… Continue reading HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER “HBNB”